ProQuest Financial LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 176,441 shares at $83.02 ($14.7M) on 2017-03-31, disclosed to the SEC on 2017-04-03.
Open-market sale of $14.7M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.00 | 6,223 | $517K | 3.5% |
| 2 | $83.02 | 23,689 | $2.0M | 13.4% |
| 3 | $83.02 | 23,689 | $2.0M | 13.4% |
| 4 | $83.13 | 61,420 | $5.1M | 34.8% |
| 5 | $83.13 | 61,420 | $5.1M | 34.8% |
| Total | $83.10 avg | 176,441 |
| $14.7M |
| 100% |
| Filing → |